What Lies Beneath: Looking Beyond Tumor Genetics Shows the Complexity of Signaling Networks Underlying Drug Sensitivity.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004715
- By:
- Publication type:
- Article
Works matching IS 19450877 AND DT 2013 AND VI 6 AND IP 294
Results: 6
1
2
mTORC1 Status Dictates Tumor Response to Targeted Therapeutics.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004632
- By:
- Publication type:
- Article
3
Focus Issue: Networking Cancer Treatment Strategies.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004723
- By:
- Publication type:
- Article
4
Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004014
- By:
- Publication type:
- Article
5
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004652
- By:
- Publication type:
- Article
6
Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines.
- Published in:
- Science Signaling, 2013, v. 6, n. 294, p. 1, doi. 10.1126/scisignal.2004379
- By:
- Publication type:
- Article